Changes in cyclin-dependent kinase 2 and p27(kip1) accompany glial cell differentiation of central glia-4 cells

被引:0
|
作者
Tikoo, R
CasacciaBonnefil, P
Chao, MV
Koff, A
机构
[1] CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,PROGRAM MOL BIOL,NEW YORK,NY 10021
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The generation of different glial cell types in the central nervous system depends upon a wide variety of proliferative and differentiative signals. Here we report that changes in the levels of cyclin-dependent kinase 2 (CDK2) and the cell cycle inhibitor p27(kip1) accompany the differentiation of central glia-4 (CG-4) progenitor cells to an astrocytic cell phenotype in the presence of fetal calf serum. Although a decrease in CDK2 levels was observed in both oligodendrocyte and astrocyte cells derived from CG-4 cells, a striking increase in the levels of p27 was observed during the differentiation of astrocyte cells. In astrocyte cell extracts, inhibition of CDK2 activity could be overcome with exogenously added cy clin E. Furthermore, depletion of p27 from astrocyte extracts lowered the amount of cyclin E required for CDK2 activation. Taken together, these results suggest that the inhibitory action of p27 upon cyclin E-CDK2 may prevent entry of cells into the S phase and regulate the progression of CG-4 cells toward an astrocytic lineage.
引用
收藏
页码:442 / 447
页数:6
相关论文
共 50 条
  • [31] Angiotensin II (A II) stimulates induction of the cyclin-dependent kinase inhibitor p27(Kip1) in LLC-PK1 cells.
    Wolf, G
    Schroeder, R
    Stahl, RAK
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2102 - A2102
  • [32] Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1
    Lei, WL
    Liu, F
    Ness, SA
    [J]. BLOOD, 2005, 105 (10) : 3855 - 3861
  • [33] Crystal structure of the p27(Kip1) cyclin-dependent-kinase inhibitor bound to the cyclin A Cdk2 complex
    Russo, AA
    Jeffrey, PD
    Patten, AK
    Massague, J
    Pavletich, NP
    [J]. NATURE, 1996, 382 (6589) : 325 - 331
  • [34] Downregulation of cyclin-dependent kinase 2 activity and cyclin a promoter activity in vascular smooth muscle cells by p27(KIP1), inhibitor of neointima formation in the rat carotid artery
    Chen, DH
    Krasinski, K
    Chen, DF
    Sylvester, A
    Chen, J
    Nisen, PD
    Andres, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10): : 2334 - 2341
  • [35] Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma
    Tsuchida, R
    Miyauchi, J
    Shen, LS
    Takagi, M
    Tsunematsu, Y
    Saeki, M
    Honna, T
    Yamada, S
    Teraoka, H
    Kato, JY
    Mizutani, S
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (09): : 1000 - 1006
  • [36] Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27(Kip1)
    Wolf, G
    Stahl, RAK
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (06) : 2112 - 2119
  • [37] Regulation of p27(Kip1) by cyclin E-Cdk2
    Roberts, JM
    Sheaff, R
    Clurman, B
    Groudine, M
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 5 - 5
  • [38] Cyclin E-CDK2 is a regulator of p27(Kip1)
    Sheaff, RJ
    Groudine, M
    Gordon, M
    Roberts, JM
    Clurman, BE
    [J]. GENES & DEVELOPMENT, 1997, 11 (11) : 1464 - 1478
  • [39] Changes in the activity of cyclin-dependent kinase 2 and cyclin-dependent kinase 5 accompany differentiation of rat primary oligodendrocytes
    Tang, XM
    Cambi, F
    Strocchi, P
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 120 - 120
  • [40] Regulation of the cyclin-dependent kinase inhibitors, p27 kip1 and p21cip1, by Rho requires ERK activation in breast cancer cells.
    Welsh, CF
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S165 - S166